Given that Th17 cells are found not only in the peripheral blood but also in the inflamed kidney in patients with SLE [102, 103], blockade of IL-17 or IL-23, which is important for IL-17 production by Th17 cells, may help to control SLE pathogenesis. This evidence concerns the gene IL23A and systemic lupus erythematosus.